And does the drug approval process seriously cost $200 million. I imagine it is not cheap, but that number seems very high for such small trial groups and a highly motivated/cooperative regulatory agency.
The FDA does have an orphan drug program that would seem to apply (if non-patentable) and could help fund clinical trials but I don’t know how much else of the process it will pay for.
Except literally every single country on this planet because they all want to go out of lockdown and restart their economy
Entities that actually have expertise and capability in clinical development of such complicated biologics get through this process by burning billions of dollars. These billions are provided by investors who must have some reasonable chance at making a profit (or at least not losing a lot of money). Non-profit enterprises simply don't have the money or the expertise. The government has no expertise in the development path. The U.S. gov't (through the FDA) has vast amounts of expertise in analyzing clinical trial proposals and data, but not actually running them.
The public is not as likely to organize their interests and establish a competent lobbying strategy. Just not enough in it for a single person for them to pay attention.